← Leaderboards
Zhenghe Wang
Case Western Reserve University
$15,658,585
Attributed
$17,914,386
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,914,386 · 13
By mechanism
R01$13,646,668 · 6
P50$2,625,169 · 2
R21$1,145,960 · 2
UH2$377,579 · 1
P30$119,010 · 2
Top collaborators
- Henri Brunengraber5 shared
- Peter Christopher Scacheri4 shared
- Joseph Edward Willis4 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Sanford D Markowitz$49,710,196
- Henri Brunengraber$19,168,451
- Bingcheng Wang$12,028,840
- Joseph Edward Willis$7,788,271
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMutationCancer CellInnovationColorectal CancerMutantTumorOncogenicMutateGenesTumor GrowthTumor XenograftCellsColon CarcinomaCell LineCancer EtiologyUnited StatesCessation Of LifeSignal TransductionKnock-In MouseSuccessGrowthFuturePhosphotransferases
Grant awards (55)
Role of PTPRT in colon cancer progression and metastasis$881,958
R01 · FY2025 · CA · contact PI
Role of Erbb3 kinase activity in colorectal tumorigenesis.$436,262
R01 · FY2025 · CA · contact PI
Mechanisms of metabolic reprogramming by PIK3CA oncogenic mutations$402,500
R01 · FY2025 · CA · contact PI
Mechanisms of PIK3CA helical domain mutations driving colorectal tumorigenesis$400,890
R01 · FY2025 · CA · contact PI
Role of Erbb3 kinase activity in colorectal tumorigenesis.$222,180
R01 · FY2025 · CA · contact PI
Cancer Genomics and Epigenomics$56,909
P30 · FY2025 · CA · contact PI
Role of Erbb3 kinase activity in colorectal tumorigenesis.$429,115
R01 · FY2024 · CA · contact PI
Role of PTPRT in colon cancer progression and metastasis$418,930
R01 · FY2024 · CA · contact PI
Mechanisms of metabolic reprogramming by PIK3CA oncogenic mutations$402,500
R01 · FY2024 · CA · contact PI
Mechanisms of PIK3CA helical domain mutations driving colorectal tumorigenesis$380,848
R01 · FY2024 · CA · contact PI
Role of Erbb3 kinase activity in colorectal tumorigenesis.$136,315
R01 · FY2024 · CA · contact PI
GI Cancer Genetics Research Program$62,101
P30 · FY2024 · CA · contact PI
Role of PTPRT in colon cancer progression and metastasis$432,159
R01 · FY2023 · CA · contact PI
Role of Erbb3 kinase activity in colorectal tumorigenesis.$425,612
R01 · FY2023 · CA · contact PI
Mechanisms of PIK3CA helical domain mutations driving colorectal tumorigenesis$392,871
R01 · FY2023 · CA · contact PI
Role of PTPRT in colon cancer progression and metastasis$440,979
R01 · FY2022 · CA · contact PI
Role of Erbb3 kinase activity in colorectal tumorigenesis.$425,612
R01 · FY2022 · CA · contact PI
Mechanisms of PIK3CA helical domain mutations driving colorectal tumorigenesis$392,871
R01 · FY2022 · CA · contact PI
Role of Erbb3 kinase activity in colorectal tumorigenesis.$434,298
R01 · FY2021 · CA · contact PI
Mechanisms of PIK3CA helical domain mutations driving colorectal tumorigenesis$400,890
R01 · FY2021 · CA · contact PI
Project 4: Targeting Glutamine Metabolism in Colorectal Cancer Harboring PIK3CA Mutations$232,499
P50 · FY2021 · CA · contact PI
Mechanisms of metabolic reprogramming by PIK3CA oncogenic mutations$379,817
R01 · FY2020 · CA · contact PI
Project 4: Targeting Glutamine Metabolism in Colorectal Cancer Harboring PIK3CA Mutations$275,312
P50 · FY2020 · CA · contact PI
Mechanisms of metabolic reprogramming by PIK3CA oncogenic mutations$366,673
R01 · FY2019 · CA · contact PI
Project 4: Targeting Glutamine Metabolism in Colorectal Cancer Harboring PIK3CA Mutations$287,968
P50 · FY2019 · CA · contact PI
High throughput screen for GPT2 inhibitors to target PIK3CA-mutant cancers$168,779
UH2 · FY2019 · CA · contact PI
Mechanisms of metabolic reprogramming by PIK3CA oncogenic mutations$383,725
R01 · FY2018 · CA · contact PI
Project 4: Targeting Glutamine Metabolism in Colorectal Cancer Harboring PIK3CA Mutations$308,389
P50 · FY2018 · CA · contact PI
High throughput screen for GPT2 inhibitors to target PIK3CA-mutant cancers$208,800
UH2 · FY2018 · CA · contact PI
Mechanisms of metabolic reprogramming by PIK3CA oncogenic mutations$389,328
R01 · FY2017 · CA · contact PI
Mechanisms of suppression of colon cancer by receptor tyrosine phosphatase PTPRT$292,112
R01 · FY2017 · CA · contact PI
Project 4: Targeting Glutamine Metabolism in Colorectal Cancer Harboring PIK3CA Mutations$288,535
P50 · FY2017 · CA · contact PI
Mechanisms of metabolic reprogramming by PIK3CA oncogenic mutations$394,667
R01 · FY2016 · CA · contact PI
Mechanisms of suppression of colon cancer by receptor tyrosine phosphatase PTPRT$292,112
R01 · FY2016 · CA · contact PI
Identifying Mutational Drivers of Late Stage Colon Cancer$306,209
P50 · FY2015 · CA
Mechanisms of suppression of colon cancer by receptor tyrosine phosphatase PTPRT$292,112
R01 · FY2015 · CA · contact PI
Next-generation mouse gene-targeting technology to model tumorigenesis$206,843
R21 · FY2015 · CA · contact PI
Identifying Mutational Drivers of Late Stage Colon Cancer$301,405
P50 · FY2014 · CA
Mechanisms of suppression of colon cancer by receptor tyrosine phosphatase PTPRT$283,349
R01 · FY2014 · CA · contact PI
Next-generation mouse gene-targeting technology to model tumorigenesis$234,077
R21 · FY2014 · CA · contact PI
Identifying Mutational Drivers of Late Stage Colon Cancer$308,257
P50 · FY2013 · CA
Mechanisms of suppression of colon cancer by receptor tyrosine phosphatase PTPRT$292,112
R01 · FY2013 · CA · contact PI
Next-generation mouse gene-targeting technology to model tumorigenesis$241,316
R21 · FY2013 · CA · contact PI
Developing novel technology for mapping dynamic oncoprotein interaction networks$224,691
R21 · FY2013 · CA · contact PI
Identifying Mutational Drivers of Late Stage Colon Cancer$316,595
P50 · FY2012 · CA
Developing novel technology for mapping dynamic oncoprotein interaction networks$239,033
R21 · FY2012 · CA · contact PI
Mechanisms of suppression of colon cancer by receptor tyrosine phosphatase PTPRT$284,744
R01 · FY2011 · CA · contact PI
Development of a universal tagging method for genome wide ChIP analyses$388,575
R01 · FY2010 · HG · contact PI
Mechanisms of suppression of colon cancer by receptor tyrosine phosphatase PTPRT$293,550
R01 · FY2010 · CA · contact PI
Development of a universal tagging method for genome wide ChIP analyses$392,500
R01 · FY2009 · HG · contact PI
Mechanisms of suppression of colon cancer by receptor tyrosine phosphatase PTPRT$293,550
R01 · FY2009 · CA · contact PI
Development of a universal tagging method for genome wide ChIP analyses$191,352
R01 · FY2009 · HG · contact PI
Development of a universal tagging method for genome wide ChIP analyses$392,500
R01 · FY2008 · HG · contact PI
Mechanisms of suppression of colon cancer by receptor tyrosine phosphatase PTPRT$293,550
R01 · FY2008 · CA · contact PI
Mechanisms of suppression of colon cancer by receptor tyrosine phosphatase PTPRT$293,550
R01 · FY2007 · CA · contact PI